Geneva, June 4 -- International Clinical Trials Registry received information related to the study (NCT06987474) titled 'Capella Scientia Development Study' on May 16.
Study Type: Observational
Primary Sponsor: Alcon Research
Condition:
Cataract
Intervention:
Device: Unity DX and SMARTCataract DX (SCDX) Biometer
Device: IOLMaster 700 Biometer
Recruitment Status: Not recruiting
Date of First Enrollment: June 2025
Target Sample Size: 400
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT06987474
Disclaimer: Curated by HT Syndication....